scholarly article | Q13442814 |
P2093 | author name string | Xianshu Gao | |
Xia He | |||
Hongliang Yu | |||
Dayong Gu | |||
Xiuhua Bian | |||
P2860 | cites work | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis | Q24606203 |
Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
Measuring inconsistency in meta-analyses | Q27860655 | ||
Meta-analysis in clinical trials | Q27860779 | ||
Assessing the quality of reports of randomized clinical trials: is blinding necessary? | Q27860973 | ||
Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study | Q28750315 | ||
Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma | Q32073414 | ||
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. | Q50986703 | ||
An elementary introduction to Bayesian computing using WinBUGS. | Q52064633 | ||
A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma | Q58876646 | ||
Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma | Q58876717 | ||
Nasopharyngeal carcinoma | Q59344163 | ||
Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma | Q59647312 | ||
Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial | Q59647334 | ||
A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma | Q71742122 | ||
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 | Q74463750 | ||
Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Grou | Q83985307 | ||
Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials | Q86647993 | ||
Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma | Q86756671 | ||
Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. | Q33230301 | ||
Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial | Q33600403 | ||
The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase iii randomized trials | Q33719825 | ||
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies | Q35612977 | ||
Bayesian methods for evidence synthesis in cost-effectiveness analysis | Q36381197 | ||
Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma | Q40402777 | ||
Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate? | Q40486189 | ||
Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal ca | Q40833105 | ||
Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma | Q42969004 | ||
A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients | Q43550144 | ||
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions | Q43920062 | ||
A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma | Q43986816 | ||
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie | Q44047357 | ||
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival | Q44315391 | ||
Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study | Q44958698 | ||
A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. | Q46090271 | ||
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience | Q46116207 | ||
Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china | Q46601075 | ||
Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group | Q46726899 | ||
Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results | Q46757682 | ||
Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr | Q50104967 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chemoradiotherapy | Q5090613 |
P304 | page(s) | 159-170 | |
P577 | publication date | 2016-01-05 | |
P1433 | published in | OncoTargets and Therapy | Q7092081 |
P1476 | title | The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trials | |
P478 | volume | 9 |
Q53525329 | Effects of S-1 Combined with Radiotherapy in the Treatment of Nasopharyngeal Cancer: A Meta-analysis Based on Randomized Controlled Trials. |
Q36341166 | Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology. |
Q42368029 | Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma |
Q54594897 | Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. |
Q48185045 | Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United Kingdom. |
Q90279416 | Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study |
Q31146986 | What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis. |
Q54059101 | [The best multimodal treatment for locally advanced nasopharyngeal carcinoma : An update of the MAC-NPC data]. |
Search more.